The company's PBN products include protein peptide products series, which offers soypeptide tablets, milk powder, and coffee; compound bio-functional beverage series derived from honey products, marine plants, and natural herbs; vitamate oral liquid that strengthens the immune system and regulate blood lipids; and urinstopper capsule, which is used as a health supplement for children suffering from bed wetting and for middle-aged and elderly adults suffering from urinary incontinence.
American Oriental Bioengineering sells its products directly to retail stores, pharmacies, and hospitals, and to independent distributors. The company is headquartered in Harbin, China.
The Scoop: The company declared on February 14th that it will be announcing its quarterly earnings on March 12th, 2007. Analysts are expecting $106-108 million in revenues and $28 to $29 million net for 2006. Institutions will take note and start scooping up this now big board stock. Until growth slows, this is a long term winner - even Cramer is warming up to it after relentlessly bashing it from $5. The recent selloff attributed to the Chinese Government investigation into drug companies - i.e. that AOB's drugs are grandfathered - is unfounded!
I would keep this in my watchlist and notice it closely until a week before earnings, and buy on any dips from here on. Be careful though, as this is a Chinese small-cap stock and you have to you have to be ready for some volatility.
AOB 1-yr chart
Disclosure: Author has no position in AOB.